These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24231798)

  • 1. Synthesis and biological evaluation of 177Lu-DOTA-porphyrin conjugate: a potential agent for targeted tumor radiotherapy detection.
    Bhadwal M; Mittal S; Das T; Sarma HD; Chakraborty S; Banerjee S; Pillai MR
    Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):224-33. PubMed ID: 24231798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and preliminary biological evaluation of a novel 109Pd labeled porphyrin derivative for possible use in targeted tumor therapy.
    Chakraborty S; Das T; Banerjee S; Sarma HD; Venkatesh M
    Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):16-23. PubMed ID: 17372569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel 177Lu-labeled porphyrin for possible use in targeted tumor therapy.
    Das T; Chakraborty S; Sarma HD; Banerjee S; Venakatesh M
    Nucl Med Biol; 2010 Jul; 37(5):655-63. PubMed ID: 20610170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on efficacy of a novel 177Lu-labeled porphyrin derivative in regression of tumors in mouse model.
    Sarma HD; Das T; Banerjee S; Venkatesh M; Vidyasagar PB; Mishra KP
    Curr Radiopharm; 2011 Apr; 4(2):150-60. PubMed ID: 22191655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of 90Y-labeled porphyrin-DOTA conjugate: a potential molecule for targeted tumor therapy.
    Mittal S; Bhadwal M; Das T; Sarma HD; Chakravarty R; Dash A; Banerjee S; Pillai MR
    Cancer Biother Radiopharm; 2013 Nov; 28(9):651-6. PubMed ID: 23837800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 109Pd labeled 5,10,15,20-tetrakis[4-carboxymethyleneoxyphenyl]porphyrin: a potential agent for targeted tumor therapy.
    Das T; Chakraborty S; Sarma HD; Banerjee S
    Curr Radiopharm; 2012 Oct; 5(4):340-7. PubMed ID: 22935057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and preliminary biological evaluation of a 177Lu labeled sanazole derivative for possible use in targeting tumor hypoxia.
    Das T; Chakraborty S; Banerjee S; Mukherjee A; Samuel G; Sarma HD; Nair CK; Kagiya VT; Venkatesh M
    Bioorg Med Chem; 2004 Dec; 12(23):6077-84. PubMed ID: 15519153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of
    Guleria M; Das T; Amirdhanayagam J; Sarma HD; Dash A
    Cancer Biother Radiopharm; 2018 Feb; 33(1):8-16. PubMed ID: 29373046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of [
    Kumar N; Guleria M; Chakraborty A; Amirdhanayagam J; Bannore TU; Damle A; Sarma HD; Das T
    Drug Dev Res; 2022 Dec; 83(8):1777-1790. PubMed ID: 36112735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic evaluation of a novel 188Re-labeled porphyrin in mice tumor model.
    Sarma HD; Das T; Banerjee S; Venkatesh M; Vidyasagar PB; Mishra KP
    Cancer Biother Radiopharm; 2010 Feb; 25(1):47-54. PubMed ID: 20187796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel [186/188Re]-labelled porphyrin for targeted radiotherapy.
    Banerjee S; Das T; Samuel G; Sarma HD; Venkatesh M; Pillai MR
    Nucl Med Commun; 2001 Oct; 22(10):1101-7. PubMed ID: 11567183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid for radiolabeling proteins.
    Chappell LL; Ma D; Milenic DE; Garmestani K; Venditto V; Beitzel MP; Brechbiel MW
    Nucl Med Biol; 2003 Aug; 30(6):581-95. PubMed ID: 12900284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and Evaluation of
    Ghosh S; Das T; Sarma HD; Dash A
    Cancer Biother Radiopharm; 2017 Sep; 32(7):239-246. PubMed ID: 28876087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear Localization Signal Enhances the Targeting and Therapeutic Efficacy of a Porphyrin-Based Molecular Cargo: A Systemic In Vitro and Ex Vivo Evaluation.
    Kumar N; Sharma AK; Guleria M; Shelar SB; Chakraborty A; Rakshit S; Kolay S; Satpati D; Das T
    Mol Pharm; 2024 May; 21(5):2351-2364. PubMed ID: 38477252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.
    Perk LR; Visser GW; Vosjan MJ; Stigter-van Walsum M; Tijink BM; Leemans CR; van Dongen GA
    J Nucl Med; 2005 Nov; 46(11):1898-906. PubMed ID: 16269605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of 177Lu- and 90Y-labeled E. coli heat-stable enterotoxin for specific targeting of uroguanylin receptors on human colon cancers.
    Giblin MF; Sieckman GL; Shelton TD; Hoffman TJ; Forte LR; Volkert WA
    Nucl Med Biol; 2006 May; 33(4):481-8. PubMed ID: 16720239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DOTA conjugate with an albumin-binding entity enables the first folic acid-targeted 177Lu-radionuclide tumor therapy in mice.
    Müller C; Struthers H; Winiger C; Zhernosekov K; Schibli R
    J Nucl Med; 2013 Jan; 54(1):124-31. PubMed ID: 23236020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [177Lu]Bz-DTPA-EGF: Preclinical characterization of a potential radionuclide targeting agent against glioma.
    Sundberg AL; Gedda L; Orlova A; Bruskin A; Blomquist E; Carlsson J; Tolmachev V
    Cancer Biother Radiopharm; 2004 Apr; 19(2):195-204. PubMed ID: 15186600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitenascin antibody 81C6 armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands.
    Yordanov AT; Hens M; Pegram C; Bigner DD; Zalutsky MR
    Nucl Med Biol; 2007 Feb; 34(2):173-83. PubMed ID: 17307125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biologic evaluation of I-123-labeled porphyrin derivative as a potential tumor-imaging agent.
    Lee JH; Moon BS; Lee TS; Chi DY; Chun KS; Cheon GJ
    Cancer Biother Radiopharm; 2007 Dec; 22(6):853-62. PubMed ID: 18158777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.